tiprankstipranks
Trending News
More News >
HBM Holdings Ltd. (HK:2142)
:2142
Hong Kong Market

Compare HBM Holdings Ltd. (2142) vs. Competitors

Compare
7 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
HBM Holdings Ltd.
HK$12.08
HK$10.51B
16.10
225.14%
1 Buy
0 Hold
0 Sell
Moderate Buy
Alphamab Oncology
HK$9.58
HK$8.68B
33.97
175.00%
2 Buy
0 Hold
0 Sell
Moderate Buy
Lepu Biopharma Co. Ltd. Class H
HK$4.98
HK$8.66B
-41.39
70.70%
Abbisko Cayman Limited
HK$13.02
HK$8.50B
44.66
159.34%
2 Buy
0 Hold
0 Sell
Moderate Buy
CStone Pharmaceuticals
HK$5.34
HK$7.80B
-17.23
129.49%
Shandong Boan Biotechnology Company., Limited. Class H
HK$8.33
HK$5.18B
134.79
-4.25%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2142
HBM Holdings Ltd.
11.90
8.16
218.18%
HK:9966
Alphamab Oncology
8.91
5.58
167.57%
HK:2157
Lepu Biopharma Co. Ltd. Class H
4.66
1.77
61.25%
HK:2256
Abbisko Cayman Limited
12.50
7.68
159.34%
HK:2616
CStone Pharmaceuticals
5.37
3.14
140.81%
HK:6955
Shandong Boan Biotechnology Company., Limited. Class H
8.33
-0.37
-4.25%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts